The annual Fed conference in Jackson Hole, Wyoming begins later on Thursday and will host central bankers from around the world. The highlight is expected to be Fed Chair Jerome Powell’s speech on ...

Investing.com -- Bilibili Inc. reported a return to profitability in the second quarter of 2025, but shares fell 3.5% premarket on Thursday as investors appeared unimpressed despite the company ...

Investing.com -- Kansas City Fed President Jeffrey Schmid indicated Thursday that the Federal Reserve is not in a hurry to cut interest rates, citing inflation that remains above the central bank’s 2% ...

From a sectoral perspective, Consumer Discretionary faces “a combination of margin pressure and weaker pricing power,” leading to underperformance. Industrials are seen benefiting from near-shoring ...

Investing.com -- Sarepta Therapeutics (NASDAQ: SRPT) stock declined 3.3% in pre-market trading Thursday after the company announced a refinancing of approximately $700 million of its 1.25% Convertible ...

Investing.com -- China Petroleum (OTC: SNPTY) & Chemical Corp., known as Sinopec (OTC: SHIIY ), reported a 40% decline in net profit for the first half of 2025, as lower oil prices weighed on the ...

Investing.com -- Barclays (LON: BARC) has raised its forecast for euro area inflation in 2025, now expecting headline consumer prices to average 2.1% compared with the 2% projection it published in ...

Walmart (NYSE: WMT) stock fell 2.7% after the retail giant reported mixed second-quarter results, with revenue exceeding expectations but earnings falling short of analyst estimates. The retail giant ...

* BASELINE U.S. TARIFF RATE ON EU GOODS: Almost all EU goods entering the U.S. will be subject to a 15% baseline tariff. The 15% tariff is not added to any existing rates. It is designed to be the ...

“This fall, it’s going to be coming to your car, to your TV, and to your smart speakers and smart display in the home... it’s going to be everywhere you are. We are even working on smart glasses with ...

Investing.com -- Morgan Stanley has initiated coverage of Trevi Therapeutics (NASDAQ: TRVI) with an “overweight” rating and a price target of $18. The brokerage flags Trevi’s development of Haduvio, ...

WASHINGTON (Reuters) -The United States and the European Union on Thursday locked in a framework trade deal reached last month that includes a 15% U.S. tariff on most EU imports, including autos, ...